ALPHA TRIBE

Aurobindo Pharma LimitedUpdates, 29-08-2025: General Updates

29-08-2025 | 10:07 pm

Aurobindo Pharma's subsidiary Apitoria Pharma received 5 procedural US FDA observations for its API unit. Importantly, no data integrity issues were reported, and the company states no financial or operational impact. They plan to respond to the FDA.

No comments yet. Be the first to comment!

All announcements from Aurobindo Pharma Limited